pharmaceutical investing KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
pharmaceutical investing KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
E-Power Resources Inc. Announces Flow-Through and Hard Dollar Private Placements to Fund Summer Work Program
Juggernaut Exploration: Advancing High-grade Precious Metals Assets in Northern BC’s Golden Triangle
New INNspired Article Spotlights Rare Earth Recycling as a Strategic Investment Opportunity in U.S. Critical Mineral Supply Chain
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
